CAJ | 학술논문

长期吸入糖皮质激素( ICS)是支气管哮喘长期控制的首选用药。学龄前儿童间歇性支气管哮喘发病率高，自然缓解率高，临床特征多变，需要个体化治疗，以达到最佳控制的目的。大部分哮喘儿童可以采用急性发作或有发作先兆的控制治疗方案，即间断高剂量ICS治疗或白三烯受体调节剂，必要时联合支气管舒张剂，取代长期低剂量ICS治疗学龄前间歇性支气管哮喘。
장기흡입당피질격소( ICS)시지기관효천장기공제적수선용약。학령전인동간헐성지기관효천발병솔고，자연완해솔고，림상특정다변，수요개체화치료，이체도최가공제적목적。대부분효천인동가이채용급성발작혹유발작선조적공제치료방안，즉간단고제량ICS치료혹백삼희수체조절제，필요시연합지기관서장제，취대장기저제량ICS치료학령전간헐성지기관효천。
Daily inhaled corticosteroids( ICS) is the primary drug to control asthma. Intermittent asthma with high incidence among preschoolers is featured with high probability of natural relief and variable clinical manifestations,suggesting that itneeds individualized treatment to better control asthma. An intermittent high-dose ICS or leukotriene receptor antagonist in response to symptoms, is an emerging strategy for control of intermittent asthma in acute attack or pre-attack, combined with bronchial dilation agent if necessary, to replace daily low-dose ICS treating intermittent asthma among preschoolers.